Hua Li

机构：Qingdao University, Betta Pharmaceuticals (China), Affiliated Hospital of Qingdao University · ORCID：0000-0001-7801-7409

发表论文 50 篇 · 总被引 498 次 · h-index 12

代表论文

• Long-Term Survival Among Histological Subtypes in Advanced Epithelial Ovarian Cancer: Population-Based Study Using the Surveillance, Epidemiology, and End Results Database (2021 · JMIR Public Health and Surveillance · 被引 27)
• Caveolin-1 and Sox-2 are predictive biomarkers of cetuximab response in head and neck cancer (2021 · JCI Insight · 被引 19)
• Natural cross-linker-stabilized acellular porcine corneal stroma for lamellar keratoplasty (2020 · Acta Biomaterialia · 被引 19)
• Identification of MEG8/miR‐378d/SOBP axis as a novel regulatory network and associated with immune infiltrates in ovarian carcinoma by integrated bioinformatics analysis (2021 · Cancer Medicine · 被引 12)
• Incorporation of biologic factors for the staging of de novo stage IV breast cancer (2020 · npj Breast Cancer · 被引 10)
• Comparison of wavefront-optimized and corneal wavefront-guided transPRK for high-order aberrations (>0.35 μm) in myopia (2022 · Journal of Cataract & Refractive Surgery · 被引 9)